🇪🇺 NexoBrid in European Union

EMA authorised NexoBrid on 18 December 2012

Marketing authorisation

EMA — authorised 18 December 2012

  • Application: EMEA/H/C/002246
  • Marketing authorisation holder: MediWound Germany GmbH
  • Local brand name: NexoBrid
  • Indication: NexoBrid is indicated in all age groups for removal of eschar in patients with deep partial- and full-thickness thermal burns.
  • Status: approved

Read official source →

NexoBrid in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is NexoBrid approved in European Union?

Yes. EMA authorised it on 18 December 2012.

Who is the marketing authorisation holder for NexoBrid in European Union?

MediWound Germany GmbH holds the EU marketing authorisation.